PROFUSA, INC.
Pioneering real-time biochemistry that drives AI-led, personalized healthcare technologies.
SOUTH SAN FRANCISCO, United States · Founded 2015 · $57.0M raised
- Headquarters
- SOUTH SAN FRANCISCO, California
- Employees
- 11–50
- Founded
- 2015
- Business Model
- B2B
- Website
- profusa.com
- Total Funding
- $57.0M
- Last Round
- $12.0M Convertible NoteOct 2025
- Rounds
- 2
About
Profusa is a commercial-stage digital health company (NASDAQ: PFSA) pioneering tissue-integrating biosensors that continuously monitor body chemistry in real time. Their Lumee™ platform measures tissue oxygen and glucose levels and has received FDA and CE authorization. Originally SBIR-funded through DARPA and NIH, Profusa now operates as a publicly traded company focused on AI-led personalized healthcare.
Summary
PROFUSA, INC. is a Biotech company based in SOUTH SAN FRANCISCO, United States, founded in 2015. It has raised $57.0M in total across 2 rounds, most recently a $12.0M Convertible Note round in Oct 2025. Investors include VMS Investment Group, Maxim Integrated and 3E Bioventures Capital.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...